No data to support delayed vaccine booster shot, says BioNTech

“The safety and efficacy of the vaccine has not been evaluated on different dosing schedules as the majority of trial participants received the second dose within the window specified in the study design,” the companies said in a joint statement, referring to prime and a booster shots given three weeks apart.

from Hindustan Times - world https://bit.ly/38Yt4BD
https://ift.tt/2zbki14